Andrea Alimonti: Catalogue data in Autumn Semester 2020 |
| Name | Prof. Dr. Andrea Alimonti |
| Field | Experimental Oncology and Translational Cancer Medicine |
| Address | Institute of Oncology Research Via F. Chiesa 5 6500 Bellinzona SWITZERLAND |
| Telephone | +4158 6667115 |
| andrea.alimonti@hest.ethz.ch | |
| Department | Health Sciences and Technology |
| Relationship | Full Professor |
| Number | Title | ECTS | Hours | Lecturers | |
|---|---|---|---|---|---|
| 376-0303-00L | Colloquium in Translational Science (Autumn Semester) | 1 credit | 1K | M. Ristow, A. Alimonti, N. Cesarovic, C. Ewald, V. Falk, J. Goldhahn, K. Maniura, J. Mitchell, R. M. Rossi, S. Schürle-Finke, G. Shivashankar, E. Vayena, V. Vogel | |
| Abstract | Current topics in translational medicine presented by speakers from academia and industry. | ||||
| Learning objective | Getting insight into actual areas and problems of translational medicine. | ||||
| Content | Timely and concise presentations of postgraduate students, post-docs, senior scientists, professors, as well as external guests from both academics and industry will present topics of their interest related to translational medicine. | ||||
| Prerequisites / Notice | No compulsory prerequisites, but student should have basic knowledge about biomedical research. | ||||
| 377-0517-00L | Oncology  Only for Human Medicine BSc | 2 credits | 2V | A. Alimonti, A. Calcinotto, A. Stathis, J.‑P. Theurillat | |
| Abstract | Advances in our knowledge of cancer genetics and the immune system are changing the ways in which we treat various types of cancer. This is a unique course designed to help students to learn about cutting-edge principle of cancer genetics, targeted and immunotherapies from leading expert in the field. | ||||
| Learning objective | Students will learn basic concepts of cancer patient’s management and anti-cancer therapy both clinically approved and experimental. | ||||
| Content | Basic knowledge in oncology - The cancer outbreak and its prevention - Tumor diagnostic, imaging and screening - Basic principle of cancer managment (neo-adjuvant, adjuvant, palliative. RT/Surgery/CT) - Management of tumor recurrence and Follow up Immuno-oncology - The promise of Immuno-oncology - Basic Tumor Immunology - Checkpoint Blockade - CAR T and other experimental Immunotherapies Oncology practice - Clinical application: Evidence Based Medicine in oncology - Clinical application: Immunology - Clinical application: Chemo-radiotherapy and Theragnostic - Clinical application: Targeted therapy in cancer Experimental oncology - Co-clinical trial: the relevance of mouse models - Next Generation sequencing and precision oncology - Microbiota and Cancer therapy - Liquid biopsy (CTC and clusters), proteomics, circulating DNA/RNA hip or hope?). Targeted therapy - From Arsenic Trioxide and Glivec to modern targeted therapies - Cancer Genomics and Epigenomics - Basic knowledge of signal transduction and cancer metabolism - Mechanism of resistance to targeted therapies Experimental oncology 2 - Senescence therapy and senolytic - Cancer metabolism (therapy and imaging) - Nanomedicine and cancer (approved and experimental) - How to do Oncology in the Big Pharma | ||||
| Prerequisites / Notice | Voraussetzungen: LE 377-0105-00L Bewegungsapparat LE 377-0107-00L Nervensystem LE 377-0201-00L Herz-Kreislauf-System LE 377-0203-00L Atmungs-System LE 377-0205-00L Nieren und Homöostase LE 377-0301-01L Blut, Immunsystem LE 377-0301-02L Ernährung und Verdauung LE 377-0301-03L Endokrinologie, Stoffwechsel LE 377-0401-00L Sinnesorgane LE 377-0403-00L Haut und Anhangsorgane | ||||